Drug-eluting stents--safety concerns.
Conti
C Richard
CR
D023903:Coronary Restenosis / Q000209:etiology*; D003328:Coronary Thrombosis / Q000209:etiology*; D016503:Drug Delivery Systems; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017239:Paclitaxel / Q000009:adverse effects; D012449:Safety; D020123:Sirolimus / Q000009:adverse effects; D015607:Stents / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus